Gene Film LLC
Raised
$25K
Investors
1
Min Invest
$25,000
Is this your company or fund? Claim this page free, or verify it and carry the Verified Issuer mark.
AltStreet Analysis
·Generated from EDGAR primary sources
Gene Film LLC is a Texas-formed entity that filed a Form D on 2026-11-12 under the Rule 506(b) exemption, reporting $25,000 raised from a single investor at a $25,000 minimum investment, structured as equity securities. The filing lists Cameron Berkman and Lauren Salatich as executive officers; no first sale date is disclosed and no parent platform or related entities have been matched in available data.
This is a very small, single-investor 506(b) equity raise, well below typical institutional alternative investment thresholds, and consistent with an early-stage or special-purpose entity rather than a broadly marketed fund. The $25K minimum matching the full raise amount suggests this filing may represent a seed or initial closing rather than an ongoing capital formation effort.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govFilings on Record
Every filing AltStreet's ledger holds for this CIK, newest first. Each opens the SEC archive folder.
In the Terminal
Filing events
1
latest Nov 12, 2026
Critical / warning
0 / 0
0 watch · 1 info
Statements extracted
0
none on file
NAV prints
0
none on file
Offering chains
1
raising
Latest event New filer · Nov 12, 2026
SEC.govInvestor
- 1 filing event with values and deltas, latest 2026-11-12, and alerts on the next one
- 1 offering timeline: velocity, share raised, first-sale lag, stalled flags
Pro
- This issuer against its cohort: rank by velocity and share raised among offerings filed the same quarter
- The same events, statements and NAV moves across every issuer, screenable, with unlimited watches and CSV
Counts and dates above are the free record. The values, the series and the comparisons are the seat. Loading your view…
Related Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
Cameron Berkman
Executive Officer · Austin, TX
Lauren Salatich
Executive Officer · Austin, TX
Questions About Gene Film LLC
Each answer is built from the values on the SEC filing and the AltStreet ledger, not from the issuer's marketing.
What is Gene Film LLC?
Gene Film LLC is a Texas limited liability company organized in 2022 that filed a Form D with the SEC on November 12, 2026 in the Other industry group. The filing claims Rule 506(b) for an offering of equity.
Is Gene Film LLC legit?
AltStreet does not rate legitimacy; it reports the public record. Gene Film LLC filed a Form D with the SEC on November 12, 2026 claiming Rule 506(b). A Form D is a notice of an exempt offering, not a review or approval of it. The newest notice reports $25,000 sold to 1 investor. AltStreet's enforcement record (SEC, FINRA and state actions) shows no action naming the issuer as of today. Before investing, confirm the filing on EDGAR, check the seller's registration on FINRA BrokerCheck, and read the offering documents, which a Form D does not include.
Is Gene Film LLC registered with or approved by the SEC?
No. A Form D is a notice that an issuer is selling securities under an exemption from registration, and the SEC does not review, approve, or pass on the merits of the offering. The filing shows that Gene Film LLC claimed Rule 506(b) and disclosed the items the form requires, such as the amount sold, the minimum investment, related persons, and anyone paid to sell the securities. It does not verify the issuer's claims or its business.
How much has Gene Film LLC raised?
Gene Film LLC reported $25,000 sold from 1 investor of a $1,500,000 total offering as of the Form D filed November 12, 2026.
Who can invest in Gene Film LLC?
The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. The filing reports no non-accredited investors. The minimum investment accepted from an outside investor is $25,000.
What is the minimum investment in Gene Film LLC?
The Form D lists $25,000 as the minimum investment accepted from any outside investor as of November 12, 2026. Issuers can waive their own minimums, and the figure does not include fees.
Who is selling Gene Film LLC and how are they paid?
The Form D names no recipient of sales compensation, which usually means the issuer or its affiliates are placing the securities directly. Sales commissions are reported as $0 and finders' fees as $0. Form D allows these to be estimates.
Who is behind Gene Film LLC?
The Form D lists 2 related persons: Cameron Berkman, executive officer; Lauren Salatich, executive officer. Form D Item 3 requires executive officers, directors, and promoters of the issuer to be listed.
Where is Gene Film LLC located?
The issuer's address on its SEC filings is 660 S Bagdad Rd, Suite 610, Leander, TX 78641. Its phone number of record is 7864738180. It is organized under the laws of Texas.
How long is the Gene Film LLC offering open?
The issuer indicated that the offering is intended to last more than one year. An issuer must amend its Form D annually while a continuing offering stays open, and no amendment is on record yet.
What is Gene Film LLC's revenue?
The Form D reports a revenue range of $1 - $1,000,000.
Is this your company or fund?
Free claim: add your contact details, website, team and a description to this page. The filed facts stay as filed.
Verified Issuer, $480 a year: AltStreet checks the identity of your company and the authority of the person claiming it against your filings, confirms your contact details on a stated date and again at each renewal, and marks the page so people researching you find a current, attributed profile beside the public filing record. It is not a review of any offering.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.